On Saturday, May 5, 2012, Dr. Steven Walkley, director of Rose F. Kennedy IDDRC, and Dr. Marc Patterson, a pediatric neurologist from the Mayo Clinic and a member of the RFK-IDDRC’s external advisory committee, were presented with certificates of special recognition by Senator Richard Blumenthal of Connecticut at the reception for the annual gala benefit and concert for Dana’s Angels Research Trust (DART).
DART, which is based in Stamford, CT, is dedicated to raising funds and awareness for Niemann-Pick type C (NPC) disease, a genetic brain disease that causes severe motor and cognitive dysfunction.
Philip Marella, founder of DART and father of two children with NPC disease, also presented Guardian Angel Awards to Drs. Walkley and Patterson for their contributions to NPC disease research and treatment. Cristin Davidson, a graduate student in Dr. Walkley’s lab at Einstein also was acknowledged for her discovery that a drug, cyclodextrin, is beneficial as therapy for NPC disease. Efforts are underway to initiate an FDA-approved clinical trial for the fall of 2012 using cyclodextrin to treat NPC disease.
Einstein's Nilda Soto Has Leadership Role with N.Y. State Minority Health Council
Friday, September 23, 2016
Dr. Safyer Announces Key Leadership Appointments at Montefiore
Thursday, September 22, 2016
Exploring Multiple Career Opportunities
Tuesday, August 30, 2016
Einstein-Montefiore Clinical Research Training Program Begins a New Chapter
Monday, August 22, 2016
Puzzling—and Fun—Approach to Relieving Stress
Thursday, August 11, 2016
George Washington's Dedication to Medicine
Wednesday, August 03, 2016
Gearing Up for Career Success at Einstein Ph.D. Alumni Symposium
Monday, August 01, 2016
IRACDA Fellows Show Off Their Research Skills, Education-Style
Friday, July 29, 2016
Passing of Dr. Samuel Levine Marks the End of an Era
Thursday, July 28, 2016
Einstein's Newest Ph.D. Candidates Rejoice at Qualification Jubilation
Monday, July 25, 2016
< Previous | Next >